Literature DB >> 8667028

Activation of protein kinase C augments peptide release from rat sensory neurons.

L A Barber1, M R Vasko.   

Abstract

To determine whether protein kinase C (PKC) mediates release of peptides from sensory neurons, we examined the effects of altering PKC activity on resting and evoked release of substance P (SP) and calcitonin gene-related peptide (CGRP). Exposing rat sensory neurons in culture to 10 or 50 nM phorbol 12,13-dibutyrate (PDBu) significantly increased SP and CGRP release at least 10-fold above resting levels, whereas the inactive 4alpha-PDBu analogue at 100 nM had no effect on release. Furthermore, 100 nM bradykinin increased peptide release approximately fivefold. Down-regulation of PKC significantly attenuated the release of peptides evoked by either PDBu or bradykinin. PDBu at 1 nM or 1-oleoyl-2-acetyl-sn-glycerol at 50 microM did not alter resting release of peptides, but augmented potassium- and capsaicin-stimulated release of both SP and CGRP approximately twofold. This sensitizing action of PKC activators on peptide release was significantly reduced by PKC down-regulation or by pretreating cultures with 10 nM staurosporine. These results establish that activation of PKC is important in the regulation of peptide release from sensory neurons. The PKC-induced enhancement of peptide release may be a mechanism underlying the neuronal sensitization that produces hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667028     DOI: 10.1046/j.1471-4159.1996.67010072.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

1.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia.

Authors:  M Tominaga; M Wada; M Masu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons.

Authors:  Lisa M Darby; Hongdi Meng; Jill C Fehrenbacher
Journal:  Mol Cell Neurosci       Date:  2017-04-09       Impact factor: 4.314

Review 3.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

4.  PKCɛ mediates substance P inhibition of GABAA receptors-mediated current in rat dorsal root ganglion.

Authors:  Li Li; Lei Zhao; Yang Wang; Ke-Tao Ma; Wen-Yan Shi; Ying-Zi Wang; Jun-Qiang Si
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

5.  Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.

Authors:  Ying He; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

Review 6.  Role of neurogenic inflammation in pancreatitis and pancreatic pain.

Authors:  Louis Vera-Portocarrero; Karin N Westlund
Journal:  Neurosignals       Date:  2005

Review 7.  Peripheral and central sensitization in fibromyalgia: pathogenetic role.

Authors:  Roland Staud; Michael L Smitherman
Journal:  Curr Pain Headache Rep       Date:  2002-08

8.  Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro.

Authors:  M S Gold; J D Levine; A M Correa
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

9.  The role of PKA and PKCepsilon pathways in prostaglandin E2-mediated hypernociception.

Authors:  D Sachs; Cf Villarreal; Fq Cunha; Ca Parada; Sh Ferreira
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

10.  Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression.

Authors:  Tetsuji Terashima; Qinghao Xu; Shigeki Yamaguchi; Tony L Yaksh
Journal:  Neuropharmacology       Date:  2013-06-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.